Tribenzor

utilized to address hypertension to target cardiovascular health.

Strengths: 20/5/12.5 · 40/5/12.5mg

Medicine details

Conditions
Therapeutic class

Antihypertensive Combination

Pharmacological class

ARB + Calcium Channel Blocker + Diuretic

Contraindications

hypersensitivity to components; anuria; severe renal impairment; pregnancy

Minor side effects

dizziness; fatigue; headache

Moderate side effects

peripheral oedema; hypotension; hyperuricaemia

Dosage forms

Film-coated tablet

Administration route

Oral use

Patient summary

utilized to address hypertension to target cardiovascular health.

Prescription status

POM

Manufacturer

Daiichi Sankyo

Onset Time

1–2 hours

Duration

24 hours

Storage instructions

Store at room temperature below 30°C.

Drug interactions

lithium; potassium-sparing diuretics; other antihypertensives

Age restrictions

Not for use in children.

Precautions and warnings

monitor blood pressure regularly; maintain adequate hydration; monitor electrolyte levels

Serious side effects

angioedema — requires immediate medical attention; acute renal failure — requires immediate medical attention; severe hypotension — requires immediate medical attention

Mechanism of action

Tribenzor combines three distinct antihypertensive mechanisms: olmesartan blocks angiotensin II receptors, amlodipine inhibits calcium influx in vascular smooth muscle, and hydrochlorothiazide increases sodium excretion, collectively lowering blood pressure.

Pregnancy and breastfeeding

Pregnancy: Must not be used during pregnancy as it may cause foetal harm. Breastfeeding: Not recommended.

Tribenzor

utilized to address hypertension to target cardiovascular health.

Editorial Notes

  • Active ingredient(s): Olmesartan, Amlodipine, Hydrochlorothiazide
  • Listed indication(s): Hypertension

Usually available as

  • 60 tablets - 20/5/12.5 mg1506-20-5-12-5-mg-17945
  • 60 tablets - 40/5/12.5 mg1506-40-5-12-5-mg-17953